Data from Marked Activity of Irinotecan and Rapamycin Combination toward Colon Cancer Cells In vivo and In vitro Is Mediated through Cooperative Modulation of the Mammalian Target of Rapamycin/Hypoxia-Inducible Factor-1α Axis
Authors:
- Erwan PencreachEPErwan Pencreach
- Eric GuérinEGEric Guérin
- Céline NicoletCNCéline Nicolet
- Isabelle Lelong-RebelILIsabelle Lelong-Rebel
- Anne-Claire VoegeliAVAnne-Claire Voegeli
- Pierre OudetPOPierre Oudet
- Annette K. LarsenALAnnette K. Larsen
- Marie-Pierre GaubMGMarie-Pierre Gaub
- Dominique GuenotDGDominique Guenot
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)